Literature DB >> 15503459

Drug delivery to brain by microparticulate systems.

H Süheyla Kaş1.   

Abstract

The site specific delivery of chemotherapeutic agents allows maximum concentration of an agent at a desired body site. This area specific drug delivery decreases the unwanted systemic distribution and decreases toxicity of the administered drugs. Blood-Brain Barrier (BBB) is considered to be an obstacle in delivering large number of drugs to brain. The endothelial cells forming the tubular capillaries in the brain are cemented together by intercellular tight junctions. In this way, the BBB has an important role in providing a stable extracellular environment in the central nervous system. Lack of fenestrations, very few pinocytotic vesicles, and more mitochondria are other differences of the brain capillaries which play important role in transport of drugs to brain (Fig.1). The purpose of this paper is to summarise the methods for BBB permeability modifications and to focus on various examples in delivering drugs, especially neuroncology and neuroactive drugs, to brain by microparticulate systems.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15503459     DOI: 10.1007/978-0-306-48584-8_17

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

1.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

2.  Differential reactions of microglia to brain metastasis of lung cancer.

Authors:  Bei Ping He; Jian Jun Wang; Xian Zhang; Yan Wu; Miao Wang; Boon-Huat Bay; Alex Yuang-Chi Chang
Journal:  Mol Med       Date:  2006 Jul-Aug       Impact factor: 6.354

3.  A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier.

Authors:  Delara Karkan; Cheryl Pfeifer; Timothy Z Vitalis; Gavin Arthur; Maki Ujiie; Qingqi Chen; Sam Tsai; Gerrasimo Koliatis; Reinhard Gabathuler; Wilfred A Jefferies
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.